Gamal Allam

Gamal Allam

Auto-generated profile, based on publicly available information

Gamal Allam

Department of Microbiology, College of Medicine, Taif University, Taif, Saudi Arabia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
AAAdel Abdel-Moneim
Adel Abdel-Moneim
HBHeba H. Bakery
Heba H. Bakery
GAGamal Allam
Gamal Allam


1 November 2013 in Life Sciences
Verified
Journal Article
Closed access
AAAbdelaziz S.A. Abuelsaad
Abdelaziz S.A. Abuelsaad
IMImad Mohamed
Imad Mohamed
GAGamal Allam
Gamal Allam
AAAdnan A. Al-Solumani
Adnan A. Al-Solumani

1 January 2016 in Central European Journal of Immunology
Verified
Journal Article
Open access
GAGamal Allam
Gamal Allam
EMEmad A. Mahdi
Emad A. Mahdi
AAAbdullah M. Alzahrani
Abdullah M. Alzahrani
AAAbdelaziz S.A. Abuelsaad
Abdelaziz S.A. Abuelsaad
Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown aetiology, but it is now clear that pro-inflammatory cytokines play a central role in its pathogenesis. Ellagic acid (EA) has a variety of biological activities including anti-oxidant, anti-inflammatory, and anti-cancer properties. The aim of the present study was to evaluate the potential effect of ellagic acid on the prevention and/or treatment of adjuvant induced arthritis (AIA) model in mice. Ellagic acid treatment was started one week before AIA induction and continued for three weeks after induction of AIA. Ellagic acid treatment significantly (p  0.01) inhibited foot paw oedematous swelling and attenuated AIA-associated pathology. Ellagic acid significantly (p  0.01) reduced serum levels of pro-inflammatory cytokines: interleukin 1 (IL-1), tumor necrosis factor  (TNF-), and interleukin 17 (IL-17). However, serum levels of IL-10 and interferon  (IFN-) significantly increased (p  0.01 and p  0.05, respectively), while serum level of transforming growth factor  (TGF-) did not significantly alter with EA treatment. In conclusion, these results suggest that EA attenuated AIA-associated pathology in the mouse model by downregulation of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines.

1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
GAGamal Allam
Gamal Allam
AAAdel Abdel-Moneim
Adel Abdel-Moneim
AGAsmaa M. Gaber
Asmaa M. Gaber

19 August 2016 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
ITI. M. Talaat
I. M. Talaat
ANAmre Nasr
Amre Nasr
AAA. A. Alsulaimani
A. A. Alsulaimani
HAH. Alghamdi
H. Alghamdi
KAK. A. Alswat
K. A. Alswat
GAG. Allam
G. Allam